资源描述：
《2型糖尿病患者骨质疏松症的影响因素分析与超声诊断的应用价值》由会员上传分享，免费在线阅读，更多相关内容在行业资料-天天文库。
1、AbstractObjective:1.Understandoccurrenceandinfluencefactoroftype2diabetespatientswithosteoporosis.2.Discusstheclinicalapplicationvalueofcalcanealquantitativeultrasoundonthediagnosisofosteoporosis.Methods:Collectthegeneralinformation,biochemicalindicatorsandoccurrenceofcomplica
2、tionsofendocrinologydepartmentin-hospitaltype2diabetespatientsfromDecember2013toMay2014,Dual-energyX-raybonedensityinstrumentdetectionresultwastakenasthegoldenstandardforanalysis,thepatientsof2-diabetesmellitusweredividedintotheosteoporosisgroup,non-osteoporosisgroup,andchi-sq
3、uareexaminationwasappliedforsingle-variableanalysisofdangerousfactors,andthelogisticregressionofbinaryvariablewasappliedformulti-variableanalysis,theoccurringofosteoporosisof2-diabetesmellituspatientswasobserved,andthepossibleinfluentialfactorswereanalyzed,andquantitativeultra
4、soundbonedensitydetectioninstrumentwassuedtodetectthestrengthofthepatients’calcaneus,thecharacteristiccurveofsubjectswasdrawn,andtheclinicalapplicationvalueofcalcaneusquantitativeultrasoundmethodinthediagnosisofosteoporosiswasdiscussed.Results:Univariatecorrelationanalysisshow
5、sthatduration(OR=2.684),peripheralneuropathy（OR=4.440),hypertension（OR=2.281）,coronaryheartdisease(OR=2.622）areinpositiverelationtotype2diabeticosteoporosis（P＜0.05）,whileBMI,highdensitylipoproteinareinnegativerelationtotype2diabeticosteoporosis.Multivariatecorrelationanalysiss
6、howsBMI(OR=0.311)isinnegativerelationtotype2diabeticosteoporosis（P＜0.05）,peripheralneuropathy(OR=3.795)isinpositiverelationtotype2diabeticosteoporosis（P＜0.05）.Bycalcanealquantitativeultrasounddetectionmethodanddual-energyX-raydetectionmethod,sensitivityare44.44%and34.99%formal
7、e,andfemaleT2DMpatientswithosteoporosis,whilespecificityare97.22%and99.17%respectively.Inquantitativeultrasounddetection,whenT=-1.950,subjectworkfeaturecurvelowerarea(0.807)isatitsmaximum,sensitivityis57.7%whilespecificityis89.3%.Conclusion:1.2typediabeticosteoporosisdiseasewi
8、thavarietyoffactors.Thecourseofdisease,peripheralneuropathy,h
